GALT
Price
$2.33
Change
-$0.18 (-7.17%)
Updated
Jun 27 closing price
Capitalization
147.47M
50 days until earnings call
HCWB
Price
$4.50
Change
+$0.28 (+6.64%)
Updated
Jun 27 closing price
Capitalization
9.36M
Interact to see
Advertisement

GALT vs HCWB

Header iconGALT vs HCWB Comparison
Open Charts GALT vs HCWBBanner chart's image
Galectin Therapeutics
Price$2.33
Change-$0.18 (-7.17%)
Volume$1.95M
Capitalization147.47M
HCW Biologics
Price$4.50
Change+$0.28 (+6.64%)
Volume$3.56M
Capitalization9.36M
GALT vs HCWB Comparison Chart in %
Loading...
GALT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
HCWB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
GALT vs. HCWB commentary
Jun 30, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GALT is a Buy and HCWB is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 30, 2025
Stock price -- (GALT: $2.33 vs. HCWB: $4.50)
Brand notoriety: GALT and HCWB are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: GALT: 285% vs. HCWB: 360%
Market capitalization -- GALT: $147.47M vs. HCWB: $9.36M
GALT [@Biotechnology] is valued at $147.47M. HCWB’s [@Biotechnology] market capitalization is $9.36M. The market cap for tickers in the [@Biotechnology] industry ranges from $304.6B to $0. The average market capitalization across the [@Biotechnology] industry is $2.3B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GALT’s FA Score shows that 0 FA rating(s) are green whileHCWB’s FA Score has 0 green FA rating(s).

  • GALT’s FA Score: 0 green, 5 red.
  • HCWB’s FA Score: 0 green, 5 red.
According to our system of comparison, both GALT and HCWB are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GALT’s TA Score shows that 6 TA indicator(s) are bullish while HCWB’s TA Score has 2 bullish TA indicator(s).

  • GALT’s TA Score: 6 bullish, 3 bearish.
  • HCWB’s TA Score: 2 bullish, 4 bearish.
According to our system of comparison, GALT is a better buy in the short-term than HCWB.

Price Growth

GALT (@Biotechnology) experienced а -3.72% price change this week, while HCWB (@Biotechnology) price change was -3.64% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.13%. For the same industry, the average monthly price growth was +31.22%, and the average quarterly price growth was +12.91%.

Reported Earning Dates

GALT is expected to report earnings on Aug 18, 2025.

Industries' Descriptions

@Biotechnology (+4.13% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
GALT($147M) has a higher market cap than HCWB($9.36M). GALT YTD gains are higher at: 80.620 vs. HCWB (-74.781). HCWB has higher annual earnings (EBITDA): -21.71M vs. GALT (-38.92M). GALT has more cash in the bank: 7.43M vs. HCWB (1.11M). HCWB has less debt than GALT: HCWB (13.9M) vs GALT (108M). HCWB has higher revenues than GALT: HCWB (1.45M) vs GALT (0).
GALTHCWBGALT / HCWB
Capitalization147M9.36M1,571%
EBITDA-38.92M-21.71M179%
Gain YTD80.620-74.781-108%
P/E RatioN/AN/A-
Revenue01.45M-
Total Cash7.43M1.11M671%
Total Debt108M13.9M777%
FUNDAMENTALS RATINGS
GALT: Fundamental Ratings
GALT
OUTLOOK RATING
1..100
44
VALUATION
overvalued / fair valued / undervalued
1..100
96
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
35
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
GALTHCWB
RSI
ODDS (%)
Bearish Trend 3 days ago
62%
Bullish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
75%
N/A
Momentum
ODDS (%)
Bullish Trend 3 days ago
87%
Bearish Trend 3 days ago
86%
MACD
ODDS (%)
Bullish Trend 3 days ago
81%
Bearish Trend 3 days ago
89%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
85%
Bearish Trend 3 days ago
88%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
82%
Bearish Trend 3 days ago
89%
Advances
ODDS (%)
Bullish Trend 12 days ago
79%
N/A
Declines
ODDS (%)
N/A
Bearish Trend 10 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
78%
Bullish Trend 3 days ago
79%
Aroon
ODDS (%)
Bullish Trend 3 days ago
88%
Bearish Trend 3 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
GALT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
HCWB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PENN18.280.02
+0.11%
PENN Entertainment
AUTL2.31N/A
N/A
Autolus Therapeutics plc
CHWY42.83-0.60
-1.38%
Chewy
AKA10.70-0.29
-2.64%
aka Brands Holding Corp
JVA4.25-0.14
-3.19%
Coffee Holding Co

GALT and

Correlation & Price change

A.I.dvisor tells us that GALT and RNAC have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that GALT and RNAC's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GALT
1D Price
Change %
GALT100%
-7.17%
RNAC - GALT
32%
Poorly correlated
-6.81%
SNPX - GALT
32%
Poorly correlated
+23.37%
BCAB - GALT
32%
Poorly correlated
+2.37%
AVIR - GALT
30%
Poorly correlated
-2.27%
ERAS - GALT
27%
Poorly correlated
N/A
More

HCWB and

Correlation & Price change

A.I.dvisor indicates that over the last year, HCWB has been loosely correlated with APLM. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if HCWB jumps, then APLM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HCWB
1D Price
Change %
HCWB100%
+6.64%
APLM - HCWB
45%
Loosely correlated
+1.51%
GHRS - HCWB
25%
Poorly correlated
+0.32%
ACRS - HCWB
24%
Poorly correlated
N/A
GALT - HCWB
24%
Poorly correlated
-7.17%
TRAW - HCWB
23%
Poorly correlated
N/A
More